Compare Cara Therapeutics vs Phico Therapeutics
Customers evaluate the quality of Cara Therapeutics's products using the following success metrics.
Overview
Cara Therapeutics is 20 yrs old and is based in United States.
Cara Therapeutics is a commercial-stage biopharmaceutical company that focuses on improving the lives of patients suffering from pruritus. The company's main offering is a treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis, and it is also developing treatments for pruritus in patients with non-dialysis dependent advanced chronic kidney disease, atopic dermatitis, and notalgia paresthetica. It was founded in 2004 and is based in Stamford, Connecticut.
Phico Therapeutics is 24 yrs old and is based in United Kingdom.
Phico Therapeutics operates as a biotechnology company. It develops engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, particularly those caused by multi-drug resistant bacteria. The company was founded in 2000 and is based in Cambridgeshire, United Kingdom.
Demo Video
Leadership
Derek Chalmers (Chief Executive Officer, President)
Heather Fairhead (Founder, Chief Executive Officer)
Funding
Investors
Ascent Biomedical Ventures, Mitsubishi Corporation Life Sciences Ventures
BGF, CARB-X
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Cara Therapeutics has not claimed their profile.
Work for Cara Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Cara Therapeutics?
Claim your profile now.
Information not available because Phico Therapeutics has not claimed their profile.
Work for Phico Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Phico Therapeutics?
Claim your profile now.